BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 15115227)

  • 1. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
    Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
    Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious markers in blood donors of East Delhi: prevalence and trends.
    Singh B; Kataria SP; Gupta R
    Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
    Choudhury N; Ramesh V; Saraswat S; Naik S
    Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
    Aggarwal V; Prakash C; Yadav S; Chattopadhya D
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HIV and VDRL seropositivity in blood donors of Delhi.
    Singh B; Verma M; Kotru M; Verma K; Batra M
    Indian J Med Res; 2005 Sep; 122(3):234-6. PubMed ID: 16251780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary donors-need for a second look.
    Kakkar N; Kaur R; Dhanoa J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):381-3. PubMed ID: 16295429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India.
    Singhvi A; Pulimood RB; John TJ; Babu PG; Samuel BU; Padankatti T; Carman RH
    J Trop Med Hyg; 1990 Jun; 93(3):178-82. PubMed ID: 2348495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania.
    Matee MI; Magesa PM; Lyamuya EF
    BMC Public Health; 2006 Jan; 6():21. PubMed ID: 16445860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.
    Galea G; Dow BC
    Vox Sang; 2006 Jul; 91(1):28-33. PubMed ID: 16756598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
    Pahuja S; Sharma M; Baitha B; Jain M
    Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.
    Garg S; Mathur DR; Garg DK
    Indian J Pathol Microbiol; 2001 Oct; 44(4):409-12. PubMed ID: 12035351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the prevalence of transfusion-transmissible infections among blood donors in Albania.
    Durro V; Koraqi A; Saliasi S
    Clin Lab; 2010; 56(11-12):591-5. PubMed ID: 21141446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi'an, China between 1999 and 2009.
    Ji ZH; Li CY; Lv YG; Cao W; Chen YZ; Chen XP; Tian M; Li JH; An QX; Shao ZJ
    Int J Infect Dis; 2013 Apr; 17(4):e259-62. PubMed ID: 23195637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
    Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
    Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)].
    Batina A; Kabemba S; Malengela R
    Rev Med Brux; 2007; 28(3):145-9. PubMed ID: 17708468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.